These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 755961)

  • 1. The effects of oestrogens and progestogens on the postmenopausal endometrium.
    Whitehead MI
    Maturitas; 1978 Sep; 1(2):87-98. PubMed ID: 755961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
    Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The modifying effect of progestogen on the response of the post-menopausal endometrium to exogenous oestrogens.
    Campbell S; McQueen J; Minardi J; Whitehead MI
    Postgrad Med J; 1978; 54 Suppl 2():59-64. PubMed ID: 740582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical considerations in the management of the menopause: the endometrium.
    Whitehead MI; McQueen J; Minardi J; Campbell S
    Postgrad Med J; 1978; 54 Suppl 2():69-73. PubMed ID: 740583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial disease after treatment with oestrogens and progestogens in the climacteric.
    Paterson ME; Wade-Evans T; Sturdee DW; Thom MH; Studd JW
    Br Med J; 1980 Mar; 280(6217):822-4. PubMed ID: 7370682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial thickness assessed by transvaginal ultrasound insufficiently predicts occurrence of hyperplasia during unopposed oestrogen use.
    Meuwissen JH; Oddens BJ; Klinkhamer PJ
    Maturitas; 1996 May; 24(1-2):21-30. PubMed ID: 8794430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations.
    Aylward M; Maddock J; Parker A; Protheroe DA; Ward A
    Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestradiol: the predominant intranuclear oestrogen in the endometrium of oestrogen-treated postmenopausal women.
    Whitehead MI; Lane G; Dyer G; Townsend PT; Collins WP; King RJ
    Br J Obstet Gynaecol; 1981 Sep; 88(9):914-8. PubMed ID: 7272264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of endometrial abnormalities.
    Whitehead MI
    Acta Obstet Gynecol Scand Suppl; 1986; 134():81-91. PubMed ID: 3028029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and the endometrium.
    Feeley KM; Wells M
    J Clin Pathol; 2001 Jun; 54(6):435-40. PubMed ID: 11376015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the endometrial effects of estrogens and progestins.
    Creasy GW; Kafrissen ME; Upmalis D
    Obstet Gynecol Surv; 1992 Sep; 47(9):654-78. PubMed ID: 1436909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogens and endometrial hyperplasia.
    Thom MH; Studd JW
    Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial morphology and bleeding patterns as a function of progestogen supplementation.
    Sturdee DW
    Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of endometrial cancer with progestogens.
    Gambrell RD
    Maturitas; 1986 Jul; 8(2):159-68. PubMed ID: 3747849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of postmenopausal bleeding to prevent endometrial cancer.
    Gambrell RD; Castaneda TA; Ricci CA
    Maturitas; 1978 Sep; 1(2):99-106. PubMed ID: 755962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal women.
    Sturdee DW; Wade-Evans T; Paterson ME; Thom M; Studd JW
    Br Med J; 1978 Jun; 1(6127):1575-7. PubMed ID: 656818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.